Drug Delivery

Focus on Patient Needs for Effective Drug Delivery

Today, patients with chronic conditions are increasingly administering their own medications, and recent trends point to a prevalence toward injectables, reports Graham Reynolds, VP Marketing & Innovation, West Pharmaceutical Services Inc. “We are now seeing the emergence of alternative systems such as patch injectors and more sophisticated pen systems.

No votes yet

Fentanyl Available in Unit-Dose Spray

Launched this week in the United States, SubSys (fentanyl) sublingual spray employs a customized sublingual Unit-Dose Spray (UDS) device from Aptar Pharma. SubSys is indicated for the treatment of breakthrough cancer pain (BTCP) in opioid-tolerant adult patients who are already routinely taking other opioid pain medicines around-the-clock for cancer pain.

Promoting Patient Safety through Product Quality

Deck: 
At Pharmapack Europe, next-generation packaging technology seeks to address drug makers’ concerns about contamination.

Speakers and exhibitors at Pharmapack Europe February 15-16 will be focusing on easing drug delivery while overcoming industry’s challenges.

Can’t Make It to Europe?

Don't Miss the Pharmapack Europe Conference

Plan now to visit Pharmapack Europe in Paris February 15-16. For more details on the event, visit www.pharmapack.fr. Hope to see you stop by the PMP News booth!

Wednesday

15th February 2012

9.30: Opening Address
“From Mesopotamia to modern times, THINK DIFFERENT about INNOVATION,” Patrice Noailles, Président, Seillans Investissement, France

No votes yet

Did You Read Our Most Popular Articles from 2011?

As we celebrate the end of 2011, we'd like to take time to point out the year's top articles on www.pmpnews.com. Following are the articles published this year that drew the most page views.

1. Comfort In Parenteral Delivery

Your rating: None Average: 4.8 (4 votes)

Gebauer Unveils Spray System

Gebauer Company (www.gebauer.com) has launched the Accu-Stream 360 with Sure Lock Technology to enhance the delivery of its ethyl chloride topical anesthetic skin refrigerant. The system uses 45mm slim containers from Crown Aerosol Packaging North America, a business unit of Crown Holdings, Inc., aerosol valves from Aptar Cary, a business unit of Aptargroup, Inc., and actuators designed jointly by Gebauer and Venture Plastics, Inc. and manufactured by Venture Plastics.

“Ouch less” Vaccine Delivery

With the launch of the Fluzone Intradermal influenza virus vaccine, Sanofi Pasteur has provided a new option for vaccine administration in the United States. The first flu vaccine using a microinjection system for intradermal delivery in the United States, Fluzone Intradermal is indicated for adults ages 18 to 64, an age group with traditionally low rates of immunization.
 
The system features an integrated ultra-fine 0.06-in.
No votes yet

Pulmatrix Offers Dry Powder Platform

Pulmatrix (www.pulmatrix.com), a clinical stage biotech company, has launched the iSPERSE inhaled dry powder drug delivery platform. iSPERSE’s proprietary cationic salt formulations are spray dried together with a drug or drug combinations to produce dry powders optimized for inhalation that are small in particle size, relatively dense, and highly dispersible.
 
The iSPERSE technology enables loading more drug into a dose and is relatively independent of flow rate.
Your rating: None Average: 5 (1 vote)

Tapemark Expands In Active Transdermal Systems

Tapemark (www.tapemark.com) has expanded its presence in the active transdermal systems business in acquiring Travanti Pharma Inc.’s IontoPatch business and a suite of iontophoretic technology (www.iontopatch.com), to be distributed through a newly formed entity called Travanti Medical.
 
“This acquisition was a natural extension for Tapemark. With our experience in both passive and active transdermal drug delivery, we continue to see transdermal systems as a growth area,” says Andy Rensink, president and COO, Tapemark.
No votes yet

New Routes in Dosing

Among new options, Catalent adds controlled-release and quick-dissolve formats.
Controlled-release and fast-dissolve technologies have expanded the possibilities of solid-dose delivery.
No votes yet
Syndicate content